Acuitas Therapeutics
Vancouver, BC
Reagent / Material Supplier
6 partnership announcements in press monitoring
· Last scored 2026-09-07
56.5
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (11)
○ EMA GMP
○ MHRA GMP
Quick Facts: Acuitas Therapeutics
- Signal Score
- 56.5/100 (as of 2026-09-07)
- Quality Compliance
- Assessment pending
- Headquarters
- Vancouver, BC
- Modalities
- mRNA
- Active Programs
- Data pending
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Acuitas Therapeutics
Reagent/raw material supplier.
Signal Score & Pillar Breakdown
Scores are being republished.
Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer. 6 partnership announcements found in press monitoring.
Programs
— no verified data
Sponsors— no verified data
ModalitiesmRNA
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Partnership Announcements (from press monitoring)
Financial Stability
60.0
Profile-based financial assessment
SEC FilingsPrivate company
Capacity
53.0
Profile-based capacity assessment
Recent Press11 articles
Recent News 11 articles
Genflow partners with Acuitas for gene therapy delivery tech By Investing.com - Investing.com Nigeria
Genflow partners with Acuitas for gene therapy delivery tech By Investing.com Investing.com Nigeria
Genflow partners with Acuitas for gene therapy delivery tech By Investing.com - Investing.com South Africa
Genflow partners with Acuitas for gene therapy delivery tech By Investing.com Investing.com South Africa
Genflow Secures Fully Funded LNP Collaboration With Acuitas to Advance SIRT6 Gene Therapy - TipRanks
Genflow Secures Fully Funded LNP Collaboration With Acuitas to Advance SIRT6 Gene Therapy TipRanks
Genflow partners with Acuitas for gene therapy delivery tech - Investing.com
Genflow partners with Acuitas for gene therapy delivery tech Investing.com
Genflow partners with Acuitas for gene therapy delivery tech By Investing.com - Investing.com Australia
Genflow partners with Acuitas for gene therapy delivery tech By Investing.com Investing.com Australia
Genflow partners with Acuitas for gene therapy delivery tech By Investing.com - Investing.com UK
Genflow partners with Acuitas for gene therapy delivery tech By Investing.com Investing.com UK
Circio and Acuitas partner on circular RNA CAR T therapy - Drug Target Review
Circio and Acuitas partner on circular RNA CAR T therapy Drug Target Review
Circio enters in vivo cell therapy evaluation agreement with Acuitas Therapeutics - TradingView — Track All Markets
Circio enters in vivo cell therapy evaluation agreement with Acuitas Therapeutics TradingView
Circio, Acuitas Therapeutics to Evaluate In-vivo CAR-T Cell Therapy Technology - marketscreener.com
Circio, Acuitas Therapeutics to Evaluate In-vivo CAR-T Cell Therapy Technology marketscreener.com
Circio enters in vivo cell therapy evaluation agreement with Acuitas Therapeutics - Finansavisen
Circio enters in vivo cell therapy evaluation agreement with Acuitas Therapeutics Finansavisen
Circio Holding ASA And Acuitas Therapeutics Enter In Vivo Car-T Cell Therapy Evaluation Agreement - marketscreener.com
Circio Holding ASA And Acuitas Therapeutics Enter In Vivo Car-T Cell Therapy Evaluation Agreement marketscreener.com
Frequently Asked Questions About Acuitas Therapeutics
What is Acuitas Therapeutics's CDMO Signal Score?
Acuitas Therapeutics has a Signal Score of 56/100, based on quality, operations, financial stability, and capacity data.
Evaluating Acuitas Therapeutics for a manufacturing program?
Use the free AI matchmaker to compare Acuitas Therapeutics against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Evonik Health Care
Birmingham, AL · Vancouver, BC
Signal Score: 81.5
mRNA, Biologics
Precision NanoSystems (Cytiva)
Vancouver, BC, Canada
Signal Score: 69.0
mRNA
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 91.5
Biologics, mRNA
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 88.0
AAV, Lentiviral, Plasmid, mRNA
BioNTech (Mfg Services)
Mainz, DE · Marburg, DE
Signal Score: 84.9
mRNA